Archive explorer

Browse & search snapshots

Important note

Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.

For background on coverage and capture methods, see Methods & coverage.

Browse archived sites

Browse all sources →

Licensed Natural Health Products Database (LNHPD) - User Guide March 2017 - Version 1.1 The following document provides guidance to individuals wishing to search for licensed natural health products using the Licensed Natural Health Products Database (LNHPD). Users should note…

COVID-19 Disinfectants and sanitizers - Canada.ca

Health CanadaCaptures 28Latest capture Apr 11, 2026en

COVID-19 Disinfectants and sanitizers Information about disinfectants and sanitizers for manufacturers and distributors in relation to COVID-19. Services and information Hard surface disinfectants and hand sanitizers Regulatory response, expedited licensing, quality requirements,…

Product Licensing - Canada.ca

Health CanadaCaptures 26Latest capture Apr 11, 2026en

Product Licensing The Natural Health Products Directorate (NHPD) has changed its name to the Natural and Non-prescription Health Products Directorate (NNHPD) subsequent to its recently expanded mandate to include the oversight of non-prescription and disinfectant drugs in…

Applications and Submissions - Canada.ca

Health CanadaCaptures 21Latest capture Apr 11, 2026en

Applications and Submissions As per the Natural Health Products Regulations , product and site licences are required before a natural health product can be marketed in Canada. This section explains what applications and submissions are required to meet the requirements of the…

Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP) Date: July 23, 2021 Our file number: 21-113500-270 Key messages Health Canada has proposed regulatory amendments that would restore potential access to restricted drugs Footnote 1…

Special Access Program for drugs: Guidance document for industry and practitioners Download the alternative format (PDF format, 397 KB, 29 pages) Date published: 2020-10-14 Revised date: 2022-04-11 This guidance document explains the regulatory information requirements and…

Adverse Reaction Reporting for Specific Products If you are currently suffering from a side effect - also known as an adverse reaction - you should contact your health care provider, your local health authority, or the Canadian Association of Poison Control Centres . Who can…

Compliance and Enforcement: Assisted Human Reproduction The Regulatory Operations and Enforcement Branch of Health Canada is responsible for compliance and enforcement activities related to the Assisted Human Reproduction Act (the AHR Act) and its Regulations. On this page The…

Page 2318 of 3977Showing 23171-23180 of 39762

Early release: coverage and features are still expanding.